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Background: Bcl6 is required for the development of T follicular helper and regulatory (Tfh, Tfr) 45 
cells that regulate germinal center responses. Bcl6 also impacts the function of regulatory T 46 
(Treg) cells. 47 
Objective: The goal of this study is to define the functions f Bcl6 in Treg cells including Tfr 48 
cells in the context of allergic airway inflammation (AAI). 49 
Methods: We employed a model of house dust mite (HDM) sensitization to challenge wild type, 50 
Bcl6fl/fl  Foxp3-Cre and Prdm1(Blimp1)fl/fl Foxp3-Cre mice to study the reciprocal roles of Bcl6 51 
and Blimp1 in AAI. 52 
Results: In the HDM model, Tfr cells repress the production of IgE and Bcl6+ Treg cells 53 
suppress the generation of type 2 cytokine producing ells in the lungs. In mice with Bcl6-54 
deficient Treg cells, twice as many ST2 (IL-33R)+ Tregs develop as observed in wild type mice. 55 
ST2+ Tregs in the context of AAI are Blimp1-dependent, express type 2 cytokines, and share 56 
features of visceral adipose tissue Treg cells. Bcl6-deficient Tregs are more susceptible, and 57 
Blimp1-deficient Tregs are resistant, to acquiring the ST2+ Treg cell phenotype in vitro and in 58 
vivo in response to IL-33.  Bcl6-deficient ST2+ Tregs but not Bcl6-deficient ST2+ T 59 
conventional cells strongly promote AAI when transferred into recipient mice. Lastly, ST2 is 60 
required for the exacerbated AAI in Bcl6fl/fl Foxp3-Cre mice.  61 
Conclusions: During AAI, Bcl6 and Blimp1 play dual roles in regulating Tfr activity in the 62 
germinal center and in the development of ST2+ regs that promote type 2 cytokine responses. 63 
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Key Messages:  64 
• Tfr cells limit IgE production in mice challenged by airway allergen 65 
• Bcl6 and Blimp1 reciprocally regulate ST2+ Treg development 66 
• ST2+ Tregs promote allergic airway inflammation 67 
Capsule Summary: Bcl6 attenuates allergic disease by promoting Tfr cell development to 68 
repress the allergen-specific humoral response and by limiting expansion of ST2+ Tregs.  69 
 70 
Keywords: interleukin-33, ST2, Bcl6, Blimp1, T follicular regulatory T cells, ST2-expressing 71 
regulatory T cells, allergy, asthma. 72 
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AAI: Allergic airway inflammation 76 
BAL: Bronchoalveolar lavage 77 
ChIP: Chromatin Immunoprecipitation 78 
ELISA: Enzyme-linked immunosorbent assay 79 
Foxp3: Forkhead box P3 80 
GC: Germinal center 81 
HDM: House dust mite 82 
iTreg: in vitro cultured Treg 83 
mLN: mediastinal lymph node 84 
mesLN: mesenteric lymph node 85 
PMA: Phorbol 12-myristate 13-acetate 86 
Prdm1: gene encoding Blimp1 87 
pTreg: Peripheral regulatory T cell 88 
Tconv: Conventional T cell 89 
Tfh: T follicular helper cell 90 
Tfr cells: T follicular regulatory T cells 91 
Treg: Regulatory T 92 
VAT: visceral adipose tissue 93 
WT: Wild-type 94 
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Bcl6 is a transcriptional repressor that is a central regulator of immunity with functions in 97 
T cells, macrophages and B cells (1-7). Bcl6 is critical for the germinal center response, 98 
controlling both T follicular helper (Tfh) cells and Germinal Center B (GC) B cells (1-6). Bcl6 is 99 
also expressed in a population of cells co-expressing Foxp3, the lineage defining factor for 100 
regulatory T (Treg) cells. Like Tfh and GC B cells, these cells termed T follicular regulatory (Tfr) 101 
cells co-localize to the germinal center (8-10).  102 
In the GC, Tfh cells help B cells to produce high affinity antigen specific antibodies (Abs) 103 
(11, 12). However, dysregulated Tfh cells promote B cells production of self-reactive Abs 104 
leading to autoimmune disease (13-15). It was proposed that Tfr cells regulate excessive GC 105 
reactions by suppressing proliferation of Tfh and self-reactive B cells (8-10, 16, 17). However, 106 
recent studies report that Tfr cell-derived IL-10 is important for maintenance of the GC response 107 
and provides helper functions for the antibody respon e (18). Thus, the regulatory and helper 108 
functions of Tfr cells might differ depending on the context of the immune response.  109 
In the context of allergic disease, characterized by production of Th2 cytokines such as 110 
IL-4, IL-5 and IL13, and allergen specific IgE, Bcl6 likely has multiple functions. Previous 111 
reports have shown increased allergic inflammation in mice that have germline deletion of Bcl6 112 
(19-22). Enhanced allergic inflammation was thought, at least in part, to be from effects of Bcl6-113 
deficiency in Treg populations that resulted in increased Th2 cytokines and expression of genes 114 
including Il1rl1, which encodes the IL-33R, ST2 (22). In the absence of Tfh cells, using mice 115 
that lack Bcl6 in all CD4+ T cells, there is no IgE production in response to allergen sensitization 116 
and the absence of IgE-dependent immune function (23). In allergic pulmonary inflammation it 117 
is unclear how Bcl6 influences Treg function. 118 
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In this study, we revealed that Tfr cells are critial for the allergen-specific humoral 119 
immune response during HDM induced airway inflammation. Tfr cell deficiency increased total 120 
and antigen specific IgE production and Th2 responses contributing to more severe airway 121 
inflammation. The development of ST2+ Treg cells was reciprocally regulated by Bcl6 and 122 
Blimp1. Bcl6-deficiency promoted ST2+ Treg cell development in mediastinal lymph node 123 
(mLN) and lung, and the increased pulmonary inflammation was ST2-dependent, defining a 124 
critical role for Bcl6 in restraining the development of pro-allergic ST2+ Treg cells. 125 
  126 





All mice were C57BL/6 background, except as specifid for BALB/cJ mice in strain 129 
comparisons. BALB/cJ, C57BL/6, Foxp3-CreYFP, Bcl6fl/fl Foxp3-CreYFP, Bcl6fl/fl CD4-CreYFP, 130 
Prdm1fl/fl Foxp3-CreYFP, Il1rl1-/-, Il1rl1-/-Bcl6fl/fl Foxp3-CreYFP were maintained under specific 131 
pathogen-free conditions. C57BL/6 x B6.SJL-PtprcaPepcb/BoyJ F1 mice were used as recipients 132 
for adoptive transfer experiments. All experiments were done with 6–8 week-old mice.  All 133 
experiments were performed with the approval of the Indiana University Institutional Animal 134 
Care and Use Committee. 135 
 136 
Treg cell culture  137 
Naïve CD4+CD62L+ T cells from mice were positively selected from the enriched CD4+ T cells 138 
from spleen and lymph nodes using MACS beads and columns (Miltenyi Biotec). Naive 139 
CD4+CD62L+ T cells were activated with plate-bound anti-CD3 (2 µg/ml 145-2C11 ; BioXCell) 140 
and soluble anti-CD28 (0.5 µg/ml ; BD Pharmingen) in complete culture media, Roswell Park 141 
Memorial Institute 1640 (RPMI 1640, ThermoFisher Scientific) containing  10% Fetal bovine 142 
serum (FBS, Atlanta Biologicals), 1% antibiotics (penicillin and streptomycin / stock; Pen 5000 143 
µ/ml, Strep 5000 µg/ml), 1 mM sodium pyruvate, 1 mM L-Glutamine, 2.5 ml of Non-essential 144 
amino acids (Stock; 100 X), 5mM HEPES (all from LONZA) and 57.2 µM 2-Mercapoethanol 145 
(Sigma-Aldrich), to generate Treg cells (5 ng/ml hTGF-β1, 10U/ml hIL-2, 10 µg/ml anti-IFNγ,10 146 
µg/ml anti-IL-4 or IL-33 1-10ng/ml). For splenic Treg cell culture, YFP+ Treg cells were sorted 147 
from spleen of Foxp3-CreYFP mice and activated with plate-bound anti-CD3 (2 µg/ml) and 148 
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soluble anti-CD28 (0.5 µg/ml), hIL-2 (200U/ml) with IL-33 (1 or 10 ng/ml) in complete culture 149 
media. Cells were grown at 37°C under 5% CO2 and harvested on day 3 for analysis.  150 
 151 
House dust mite extract-induced allergic airway inflammation  152 
Mice were challenged intranasally with House dust mite (HDM; Greer Laboratories) extract 153 
every other day for 16 days. HDM (25 µg) extract was diluted with PBS (25 µl) and administered 154 
into the nose. Mice were sacrificed 1 day after final tranasal challenge. Bronchoalveolar lavage 155 
(BAL) cells were collected twice by lavaging the lungs with 1 ml PBS. To prepare single cell 156 
suspension from lungs, lung tissues were chopped and incubated with 0.5 mg/ml of collagenase 157 
A (Roche) in DMEM at 37°C for 45 mins. After grindig tissues with mesh stainless steel 158 
strainer, red blood cells were removed by Ammonium-Chloride-Potassium lysing buffer 159 
(LONZA). After stopping the reaction by adding buffer (PBS with 0.5 % BSA), cells were 160 
washed with the buffer followed by filtering through 70 µm nylon mesh to remove debris. Single 161 
cell suspensions were used for flow cytometry, RNA isolation or CD4 T cell enrichment. For 162 
adoptive transfer experiment, ST2+ Treg (CD4+ ST2+ Foxp3/YFP+) or Tconv (CD4+ ST2+ 163 
Foxp3/YFP-) cells were sorted from lungs of CD45.2+ Foxp3-CreYFP, Bcl6fl/fl Foxp3-CreYFP mice 164 
(CD45.2) and 50,000 cells were transferred to naïve F1 (CD45.1) recipient mice via tail injection. 165 
Following adoptive transfer, recipient mice were challenged with HDM three times at 1 hour, 24 166 
hours, and 48 hours post adoptive transfer.  Mice were sacrificed 1 day after final intranasal 167 
challenge. 168 
 169 
Reverse transcription (RT) and quantitative real-time PCR (qPCR)_qRT-PCR 170 
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Total RNA was extracted using TRIzol reagent (ThermoFisher Scientific) and reverse 171 
transcribed using qScript cDNA synthesis kit (Quantabio). For qPCR, Taqman real time PCR 172 
assay (ThermoFisher Scientific) was used for gene expression analysis. Gene expression was 173 
normalized to housekeeping gene expression (β2-microglobulin). The relative gene expression 174 
was calculated by the change-in-threshold 2-∆CT method. All experiments were performed in 175 
duplicate in two independent experiments and results are presented as standard error of means 176 
(SEM) of biological replicates. Taqman probes sequences are listed in Table E1. 177 
 178 
Flow cytometric analysis 179 
For cytokine staining, lung or BAL cells were stimulated with Phorbol 12-myristate 13-acetate 180 
(PMA) (Sigma-Aldrich) and ionomycin (EMD Millipore) for 2 hours followed by monensin 181 
(BioLegend) for a total of 6 hours. After fixation with 1% formaldehyde for 10 mins at room 182 
temperature, cells were washed two times with FACS buffer (PBS with 0.5 % BSA). For 183 
transcription factor staining, cells were fixed with Foxp3/Transcription factor fixation buffer 184 
(eBioscience) at 4°C in dark for 30 mins or overnight. For cytokine staining and transcription 185 
factor combination staining, cells were fixed with 3.7% formaldehyde for 5 mins at 4°C followed 186 
by fixation with Foxp3/Transcription factor fixation buffer at 4°C for 3 hours. Fixed cells were 187 
permeabilized with permeabilization buffer (eBioscience) and stained for cytokines and 188 
transcription factors with fluorochrome conjugated antibodies at 4°C in dark for one hour. 189 
Stained cells were washed two times with FACS buffer and resuspended in FACS buffer for 190 
flow analysis. Fluorescent antibodies for flow cytometric analysis are listed in Table E2. 191 
 192 
ELISA 193 
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IgE capturing antibody (BD bioscience; 553413) was coated on 96 well plate (NUNC) with 194 
coating buffer (dH2O with 0.1 M NaHCO3 pH 9) and incubated at 4°C overnight. After washing 195 
the plate three times with wash buffer (PBS with 0.05% Tween-20), ELISA buffer (PBS with 2% 196 
BSA) was added to well and incubated at room temperature for one hour. After washing the plate 197 
three times with wash buffer, 10-100-fold diluted samples and standard IgE were added and 198 
incubated at 4°C overnight. The next day, after washing the plate three times with wash buffer, 199 
the biotinylated secondary antibody (BioLegend; 406904) was added and incubated at room 200 
temperature for one hour. After washing the plate thr e times with wash buffer, wash buffer with 201 
0.05% of avidin-alkaline phosphatase (Sigma-Aldrich) was added and incubated at room 202 
temperature for one hour. After washing the plate thr e times with wash buffer, substrate buffer 203 
with p-Nitrophenyl Phosphate (PNPP) (Sigma-Aldrich) was added to each well. Reaction was 204 
stopped by adding stop solution (1N NaOH) and measur d with the Biorad Microplate 680 205 
ELISA reader. For HDM specific IgE and IgG1, ELISA kits (Chondrex) were used. 206 
 207 
Chromatin Immunoprecipitation (ChIP) 208 
Splenic Treg cells (1 x 106) were stimulated for three days before being cross-linked for 15 mins 209 
with 1% formaldehyde at room temperature with rotati n. The reaction was quenched by adding 210 
0.125 M glycine and incubated at room temperature fo  5 mins.  Cells were washed with ice cold 211 
PBS two times. Fixed cells were lysed in cell lysis buffer on ice for 10 mins. Chromosomal DNA 212 
was fragmented to a size range of 200-500 bp by ultrasonic processor (Vibra-cell) (30 % 213 
amplitude for 8 sets of 10 second bursts). After sonication, debris were removed by 214 
centrifugation at 13000 rpm for 10 mins at 4°C and supernatant was transferred to new tube and 215 
diluted 10-fold with ChIP dilution buffer. After pre-clearing, the supernatant was incubated with 216 
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the ChIP antibodies for H3K27ac (Abcam), at 4oC overnight with rotation. The following day, 217 
immunocomplexes containing antibody/protein/DNA were incubated with Protein Agarose A 218 
beads at 4oC for 2~4 hours. Immunocomplexes were washed with low salt, high salt, LiCl and 219 
TE buffer. Complexes were incubated with elution buffer (0.1M NaHCO3) at room temperature 220 
for 15 mins with rotation. After centrifuging at 200  rpm for 2 mins at room temperature, the 221 
supernatant was transferred to new fresh tube. After repeating the elution step, 25 µl of 4M NaCl 222 
was added to 500 µl of supernatant to reverse cross-links at 65oC overnight. The next day, DNA 223 
was purified using phenol-chloroform extraction, and resuspended in nuclease free water and 224 
analyzed by qPCR. SYBR green master mix (Applied Biosystems) was used to measure 225 
amplification of DNA using 7500 Fast Real-Time PCR system (Applied Biosystems). After 226 
normalization to the Input DNA, the amount of output DNA of each target protein was calculated 227 
by subtracting that of the IgG control. ChIP antibodies and primer sequences are listed in Table 228 
E3. 229 
 230 
RNA-sequencing library preparation and sequencing.  231 
cDNA libraries were prepared with 1 ng of RNA per sample using Clontech SMART-Seq v4 232 
Ultra Low Input RNA Kit (TaKaRa).  Libraries were squenced with 2×75bp paired-end 233 
configuration on HiSeq4000 (Illumina) using HiSeq 3000/4000 PE SBS Kit. A Phred quality 234 
score (Q score) was used to measure the quality of sequencing. More than 90% of the sequencing 235 
reads reached Q30 (99.9% base call accuracy).  236 
 237 
RNA-Sequencing alignment and analysis.  238 
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The sequencing data were first assessed using FastQC (Babraham Bioinformatics) for quality 239 
control. All sequenced libraries were then mapped to the mouse genome (UCSC mm10) using 240 
STAR RNA-seq aligner (24). The reads distribution across the genome was assessed using 241 
bamutils (from ngsutils) (25). Uniquely mapped sequencing reads were assigned to mm10 242 
refGene genes using featureCounts (26).  Differential expression analyses were performed using 243 
edgeR v3.22.3 implemented in the Bioconductor package (27) to identify differentially expressed 244 
mRNAs between ST2+ and ST2- samples.  Biological coefficients of variation betwen the 245 
samples were estimated using an empirical Bayes appro ch under the assumption that the data 246 
follows a negative binomial distribution.  We filtered out low expression transcripts based on 247 
percentage of samples (less than 50%) and CPM cutoff of 0.5. A total of 14,943 mRNAs 248 
remained after filtering and used in the differential expression analysis by edgeR.  Statistical 249 
significance was defined as FDR p-value ≤0.05 and a fold change (FC) ≥2 of expression level 250 
between comparison of knockout mice and controls. The heat map and locus-by-locus volcano 251 
plot were performed using R package. Gene set enrichment analysis (GSEA) (28) was used for 252 
the whole genome functional enrichment analysis, baed on annotation files from Molecular 253 
Signatures Database (MSigDB) immunologic gene sets,to identify biological pathways that were 254 
significantly enriched after 3,000 times permutation.   255 
 256 
Heatmap generation and functional enrichment 257 
For visualizing the expression data obtained from the RNA-seq analysis, heatmaps were 258 
generated. Normalized counts for the most differentially expressed genes (p-value<0.05 and 259 
FDR<0.05) between ST2+ and ST2- Treg cell subtypes were given as input to generate clustered 260 
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heatmaps based on functional themes using the Morpheus platform (29) and heatmapper (30). 261 
Ontology analysis of genes was performed using gProfiler (31) to generate summaries of the 262 
enriched biologic processes.  263 




Tfr-deficiency results in exacerbated airway inflammation 265 
To define the regulatory effects of Bcl6-deficiency on allergic airway inflammation, WT, 266 
and Bcl6fl/fl  mice crossed to either Foxp3-cre or CD4-cre transgenic mice, previously shown to 267 
lack Bcl6 in specific cell populations (2, 32-38), were exposed to HDM extract every other day 268 
for 16 days (Fig 1a). Tfr cell populations were decreased in the mLN of Bcl6fl/fl Foxp3-cre mice 269 
consistent with a previous report (32) in the absence of altered Treg cell populations (Fig 1b, 1c, 270 
Figure E1a). Unexpectedly, Tfh and GC B cell populations were also significantly decreased in 271 
Bcl6fl/fl Foxp3-cre mice (Fig 1d-1g). Despite a marked decrease in GC B cells, Bcl6fl/fl Foxp3-cre 272 
mice produced increased concentrations of HDM-specific IgE and total IgE compared to WT 273 
mice (Fig 1h). Bcl6fl/fl CD4-cre mice do not produce IgE due to the lack of a GC response (Fig 274 
1d-1h). The numbers of total cells, eosinophils, neutrophils, total CD4+ T cells and Th2 cytokine-275 
producing T cells in the bronchoalveolar lavage (BAL) were significantly increased in Bcl6fl/fl 276 
Foxp3-cre mice compared to WT and Bcl6fl/fl CD4-cre mice (Fig 1i, j, Figure E1b, e). Similar to 277 
the BAL, Bcl6fl/fl Foxp3-cre mice showed increased total cells and Th2 cytokine-producing T 278 
cells in lung tissue (Fig 1k, Figure E1c, e). However, the number of IL-10 producing T cells in 279 
BAL and lung was similar between the two conditional mutant strains (Figure E1d). Consistent 280 
with a previous report (23), Bcl6fl/fl CD4-cre mice have comparable numbers of BAL cells with281 
WT mice, but increased inflammation in lung tissue (Fig. 1i, k) despite impaired IgE production. 282 
These data indicated that the lack of Bcl6 in Foxp3-expressing cells resulted in dysregulated type 283 
2 responses and exacerbated airway inflammation.  284 
 285 
Bcl6-deficiency in Treg cells leads to increased ST2+ Treg cell development 286 
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The mechanism for increased airway inflammation in Bcl6fl/fl Foxp3-cre mice was unclear. 287 
A previous report demonstrated that Bcl6-deficient splenic Treg cells expressed more Il1rl1, 288 
encoding the IL-33 receptor ST2, than WT Treg (22). Moreover, recent studies revealed that 289 
ST2+ Treg cells in the lung lost their suppressive function and promoted severe airway 290 
inflammation in response to IL-33 treatment (39). Therefore, we hypothesized that Bcl6fl/fl 291 
Foxp3-cre mice might have more ST2+ Treg cells that could be responsible for exacerbated 292 
airway inflammation. To test this, we analyzed ST2+ reg cells in lung and mLN from HDM 293 
challenged mice. Interestingly, both Bcl6fl/fl Foxp3-cre and CD4-cre mice have significantly 294 
greater percentages of the ST2+ reg cell population in Treg or total CD4+ T cell populations 295 
than WT mice (Fig 2a, b). There is an increase in the overall Treg population in the lung in 296 
Bcl6fl/fl Foxp3-cre mice compared to wild type mice, that includes an increase in the ST2- Treg 297 
population (Fig 2c). Moreover, ST2 expression in cosiderably higher on ST2+ Tregs from 298 
Bcl6fl/fl Foxp3-cre mice, compared to those from wild type mice (Fig 2d). ST2+ Treg cells are 299 
highly activated and ST2 expression is enhanced by Gata3 (40-43). We confirmed higher Gata3 300 
expression in lung- and mLN ST2+ Treg cells and an activated phenotype marked by increased 301 
expression of CD44 and decreased expression of CD62L, compared to ST2- Tregs (Figure E2a-c).   302 
Consistent with data in Figure 1j and k, ST2+ conventional T cells (Tconv) that include 303 
Th2 cells in both lung and mLN were increased in Bcl6fl/fl Foxp3-cre and CD4-cre mice (Fig 2e, 304 
f). Increased ST2+ Treg cell populations in lung and mLN of Bcl6fl/fl Foxp3-cre mice developed 305 
in the absence of altered ST2+ Tconv cells, and this effect of Bcl6-deficiency in Foxp3-306 
expressing cells was also detected in unchallenged mice (Figure E2d). Importantly, in wild type 307 
mice, Bcl6 expression is mutually exclusive to the ST2+ Treg population (Figure E2e, f). Bcl6fl/fl 308 
Foxp3-cre mice had increased ST2+ reg cells and ST2+ Tconv cell population in mesLN 309 
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compared to wild type mice (Figure E2g), suggesting the effects of Bcl6-deficiency on the ST2+ 310 
Treg population were systemic. The majority of ST2+ reg cells in lung express Helios, 311 
suggesting that most ST2+ Treg cells are thymus-derived Treg cells (Figure E2h). These data 312 
suggest that Bcl6 negatively regulates ST2+ reg cell development and that in the absence of 313 
Bcl6 there is an accumulation of ST2+ Treg cells in the lung during allergic airway inflammation. 314 
 Next, we tested whether ST2+ Treg cell development varies with genetic background, by 315 
comparing ST2+ Treg generation in HDM challenged C57BL/6 and BALB/c mice, the latter 316 
more susceptible to allergic inflammation (44, 45). While the number of ST2+ Treg and Tconv 317 
cells in lung were significantly higher in BALB/c mice, the percentages of these cell types were 318 
similar between groups (Figure E3a). The number and percentage of ST2+ Treg and Tconv cells 319 
in mLN were similar between groups (Figure E3b). In spite of difference in the number of ST2+ 320 
Treg and Tconv cells in the lung, fold changes of the number of total lung and mLN cells after 321 
HDM challenge were similar between groups (Figure E3c), suggesting that the development and 322 
function of ST2+ Treg cells are independent of genetic background.  323 
 324 
Pro-inflammatory transcriptional profile of ST2+ Treg cells in allergic airway 325 
inflammation  326 
To further define the phenotype of ST2+ Treg cells in the mLN that develop in the 327 
allergic airway model, we sorted Treg cells from mLN of HDM challenged WT mice based on 328 
the expression of YFP (Foxp3-reporter) and activation markers to identify Tfr cells (CXCR5+ 329 
PD-1+), ST2+ Treg cells (CD44high and CD62Llow ST2+), ST2- Treg cells (CD44high and 330 
CD62Llow ST2-), and naïve Treg cells (CD44low and CD62Lhigh). In Tfr cells, there is a high ratio 331 
of Bcl6 to Prdm1 (encoding Blimp1) expression that is reversed in ST2+ Treg cells (Fig 3a). We 332 
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confirmed the Bcl6 gene expression pattern by protein expression (Fig 3b). This is similar to the 333 
correlation between Blimp1 and ST2 expression in visceral adipose tissue (VAT) Treg cells (46). 334 
Expression of Bach2, a repressor of inflammatory cytokine expression in Treg cells (47, 48), was 335 
decreased in ST2+ Treg cells. However, the enhanced Foxp3 expression in ST2+ Treg cells 336 
suggested that these cells are not intrinsically unstable. Ccr7, encoding a chemokine receptor for 337 
homing to secondary lymphoid organs (49, 50), and Cxcr3, encoding a chemokine receptor for 338 
migrating to sites of type1 inflammation (51, 52), were significantly decreased in ST2+ Treg cells 339 
compared to ST2- Treg cells (Fig 3a). CCR8-expressing Treg cells are c pable of migrating to 340 
sites of Th2 cell-mediated inflammation (53), and Ccr8 mRNA was significantly enriched in 341 
ST2+ Treg cells. Importantly, Th2 cytokine genes were enriched in ST2+ Treg cells (Fig 3c). 342 
While Il4 expression was greatest in Tfr cells, ST2+ reg cells still express Il4 in greater amounts 343 
than other Treg subsets. Thus, ST2+ regs acquire a profile associated with type 2 inflammation.  344 
To further explore the ST2+ Treg cell signature in allergic airway inflammation, we 345 
performed RNA-seq on sorted ST2+ and ST2- Treg cells isolated from lung. We observed 346 
significant differences in the gene expression patterns between the two Foxp3+ populations (Fig 347 
3d). Among significant differences in the ST2+ population were increased type 2 cytokines and 348 
transcription factors, and decreased expression of genes encoding RORγt and T-bet (Fig 3e, left). 349 
We confirmed increased Th2 cytokine production in ST2+ Treg cells in protein level (Figure 350 
E4a). We observed similar patterns of differential gene expression when we analyzed ST2+ and 351 
ST2- Treg cells isolated from the lung by qRT-PCR (Figure E4b-4d). Gene set enrichment 352 
analysis identified the VAT Treg signature in the ST2+ Treg cells (Fig 3f). Indeed, there was a 353 
clear distinction in the transcriptional signatures of ST2+ and ST2- Treg cells that respectively 354 
aligned with VAT Treg cells and peripheral Treg cells (Fig 3e, right). Ontology analysis of genes 355 
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enrichment in ST2+ Treg cells revealed that ST2+ Treg cells are more sensitive to environmental 356 
cytokines and produce effector cytokines during airw y inflammation (Fig 3g). Together, these 357 
data demonstrate that ST2+ Tregs in the context of allergic lung inflammation have a pro-type 2 358 
inflammatory phenotype and share a genetic signature with VAT Tregs.  359 
 360 
Bcl6 inhibits and Blimp1 promotes ST2 expression in Treg cells  361 
To directly test whether Bcl6 is a negative regulator of ST2+ Treg cell development, 362 
splenic Treg cells from WT and Bcl6fl/fl Foxp3-cre mice were sorted and stimulated in the 363 
presence or absence of IL-33 for 3 days. Treatment with IL-33 significantly increased the 364 
frequency of ST2+KLRG1+ Tregs in WT and Bcl6-deficient cultures (Fig 4a-c). The induction of 365 
ST2 and KLRG1 on Tregs by IL-33 is consistent with previous reports (40-43), and double 366 
positive Tregs were more prevalent in resting or IL-33-treated Bcl6-deficient cultures. 367 
Interestingly, IL-33 treatment decreased Bcl6 expression while increasing Prdm1 expression (Fig 368 
4d). Similar to ex vivo Treg cells, in vitro Treg (iTreg) cells cultured with IL-33 displayed 369 
increased Il1rl1 expression while concomitantly decreasing Bcl6 mRNA (Figure E5a, b). Bcl6-370 
deficient iTreg expressed greater Il1rl1 than in WT iTreg under all conditions. We then tested 371 
whether the ST2+ Treg cell population responded to exogenous IL-33 by intranasal challenge. In 372 
WT and Bcl6fl/fl Foxp3-cre mice there was a significant increase of ST2+ Treg cells recovered 373 
from the lungs compared to untreated mice, and a significantly higher percentage in Bcl6fl/fl 374 
Foxp3-cre mice, compared to WT mice (Fig 4e). We then sorted ST2+ and ST2- Treg cells from 375 
IL-33-treated WT mice and observed enriched Gata3 expression in ST2+ Treg cells and enriched 376 
Bcl6 expression in ST2- Treg cells (Figure E5c). Bcl6-deficient splenic Treg cells did not 377 
produce Th2 cytokines in the absence of IL-33 signal ng despite expressing comparable levels of 378 
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Gata3 in the presence or absence of IL-33 signaling (Figure E5d). Treatment of ex vivo Treg 379 
cells with IL-33 increased the H3K27ac modification at the Il1rl1 and Prdm1 gene loci (Figure 380 
E5e-f). These data suggest that the IL-33/ST2 signaling pathway promotes ST2+ Treg cell 381 
development by suppressing Bcl6 and promoting Blimp1 expression. Consistent with a previous 382 
report (40), Gata3 expression was not altered afterIL-33 treatment but was increased in Bcl6 383 
deficient Treg cells, compared to wild type cells, irrespective of IL-33 treatment (Fig 4d). IL-33 384 
treatment of ex vivo Treg cells from BALB/cJ and C57BL/6 mice showed comparable ST2+ 385 
Treg cell development (Figure E5g, h). Overall, these data suggest that Bcl6 negatively regulates 386 
ST2+ Treg cell development by repressing the expression of the ST2+ Treg cell promoting 387 
transcription factors Prdm1 and Gata3. 388 
Naïve Il33-/- mice have normal ST2+ Treg cell numbers and populations in both lymphoid 389 
and non-lymphoid tissues (41). Based on that data, IL-33 may be dispensable for generation of 390 
ST2+ Treg cells (41). Similarly, IL-33 failed to induce ST2 expression in ST2- Treg cells (42). 391 
We then explored potential drivers of ST2+ Treg cell development. The IL-2/STAT5 pathway is 392 
critical for development and maintenance of Treg cells (54-58) and the IL-2/STAT5/Blimp-1 393 
axis represses Tfr cell development by inhibiting Bcl6 expression (59). In addition to Bcl6 394 
antagonistic functions (5, 59), the preferential expr ssion of Blimp1 in ST2+ Treg cells suggested 395 
that Blimp1 might be a key player. To directly test this, we stimulated splenic Treg cells from 396 
WT and Prdm1fl/fl Foxp3-cre mice with or without IL-33 for 3 days. Interestingly, Blimp1-397 
deficiency nearly eliminated the KLRG1+ population and significantly reduced the ST2+ 398 
population in basal and IL-33-treated conditions (Fig 4f-h). Consistent with the in vitro results, 399 
Blimp1-deficient mice have impaired ST2+ Treg cell percentages in naïve mice and had reduced 400 
ST2+ Treg cells during HDM induced airway inflammation (Fig 4i). Moreover, Bcl6-expressing 401 
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Treg cells in lung were increased in Blimp1-deficient mice (Figure E5i). We confirmed the 402 
positive effects of Blimp-1 deficiency on Tfr cell development in mLN (2) (Figure E5j, k). These 403 
data suggest that Blimp1 positively regulates ST2+ reg cell development, possibly by 404 
antagonizing Bcl6 expression.    405 
 406 
Bcl6-deficient ST2+ Treg cells promote airway inflammation  407 
To discriminate the effects of Bcl6-deficiency in Tregs and Tconv (which are not Bcl6-408 
deficient in Bcl6fl/fl Foxp3-cre mice), we adoptively transferred sorted lung ST2+ Treg or Tconv 409 
cells from wild type or Bcl6fl/fl Foxp3-cre mice HDM-challenged mice to naïve wild type 410 
recipient mice. After three challenges with HDM, weanalyzed the number of inflammatory cells 411 
in BAL and lung (Fig 5a). Interestingly, although the total numbers of BAL cells were similar 412 
among groups, indicative of the acute challenge (Fig 5b), mice that received Bcl6-deficient ST2+ 413 
Treg cells had the greatest increases in the number of lung cells, neutrophils, eosinophils and 414 
CD4+ T cells while wild type ST2+ Treg cell recipient mice had cell numbers comparable with 415 
PBS control (Fig 5c-d). Transferred ST2+ Tconv cells did not induce inflammation. In Bcl6-416 
deficient ST2+ Treg cell recipient mice, the vast majority of ST2+ donor cells were Foxp3+ 417 
though a subpopulation lost Foxp3 expression, suggesting that Bcl6-deficient Tregs might be 418 
unstable in this model (Fig 5e) (60). These data suggest that Bcl6 plays important roles in 419 
regulating both development and function of ST2+ reg cells which directly mediate airway 420 
inflammation.   421 
Although the mechanistic basis of the capacity of Bcl6-deficient ST2+ Treg to mediate 422 
inflammation is unclear, it is likely linked to greater expression of ST2 itself (Fig 2d), and the 423 
effects of Bcl6 on expression of ST2+ Treg cell effector molecules (63) that include Areg, Lilrb4, 424 
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and Ccl3, but not type 2 cytokines such as Il5 and Il13 (Fig 5f). This suggests that the ability of 425 
Bcl6-deficient Tregs to promote inflammation, including neutrophils, is due to increased pro-426 
inflammatory activity and chemokine production. We also observed that Bcl6-deficiency 427 
resulted in increased Prdm1 in ST2- Tregs (Fig 5f), suggesting that Blimp1 might be an 428 
important target in the acquisition of ST2 expression. 429 
 430 
ST2-deficiency compensates for the lack of Bcl6 in Treg cells during allergic airway 431 
inflammation  432 
In a previous study, Il1rl1-/- mice showed attenuated allergic airway inflammation with 433 
impaired GATA3+ Th2-like Treg cell development (39). The authors suggested that ST2 is 434 
indispensable for Th2-like Treg cell development. I parallel, our data indicate that ST2 is 435 
important for IL-33-mediated Bcl6 repression. Therefo , we questioned whether ST2-deficiency 436 
would limit the effects of Bcl6-deficiency in Treg cells during allergic airway inflammation. To 437 
answer this question, we generated Il1rl1-/-Bcl6fl/fl Foxp3-cre mice and induced HDM airway 438 
inflammation. As expected, ST2 expression was not detected on Tregs or Tconv cells in either 439 
Il1rl1-/- or Il1rl1-/-Bcl6fl/fl Foxp3-cre mice (Figure E6a). ST2-deficient mice also had a defect in 440 
the generation of Tfh, Tfr, and GC B cell development (Fig 6a). Importantly, ST2-deficiency did 441 
not compensate for the lack of Bcl6 in the Tfr cell population and the Tfr population in Il1rl1-/-442 
Bcl6fl/fl Foxp3-cre mice was similar to Bcl6fl/fl Foxp3-cre mice, but significantly less than control 443 
mice (Fig. 6a). Accordingly, the increased total and tigen-specific IgE that resulted from Tfr 444 
cell-deficiency was not compensated by simultaneous deficiency in ST2 (Fig 6b). These results 445 
suggested that Il1rl1-/-Bcl6fl/fl Foxp3-cre mice maintain the effects of Tfr-deficiency and provided 446 
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the opportunity to assess the loss of IL-33 responsive ess on the increased allergic airway 447 
inflammation in Bcl6fl/fl Foxp3-cre mice.  448 
To test this we analyzed airway inflammation and observed that Il1rl1-/- and Il1rl1-/-449 
Bcl6fl/fl Foxp3-cre mice have comparable numbers of BAL and lu g cells with WT mice (Fig 6c, 450 
6d). IL-13-producing CD4+ and GATA3+ Tconv cells were significantly decreased in Il1rl1-/-451 
Bcl6fl/fl Foxp3-cre mice compared to Bcl6fl/fl Foxp3-cre mice and restored to those observed in 452 
WT mice (Fig 6e, 6f). Despite diminished inflammation and Th2 cytokine production, lung Treg 453 
cells from Il1rl1-/-Bcl6fl/fl Foxp3-cre mice express more GATA3 than Treg cells from WT mice 454 
(Fig 6g), suggesting that Bcl6 is required for Gata3 repression. Importantly, the percentage of 455 
cells that are Foxp3+ KLRG1+, a surrogate for ST2 since the majority of KLRG1+ Treg cells are 456 
also ST2+, were similar in the absence ST2 (Figure E6b-c). This suggests that the diminished 457 
inflammation in Il1rl1-/- and Il1rl1-/-Bcl6fl/fl Foxp3-cre mice is due to the lack of ST2 but not the 458 
lack of a Treg cell compartment. Together, these data suggest that the absence of ST2 attenuates 459 
the exacerbated allergic airway inflammation that occurs in mice with Bcl6-deficient Treg cells 460 
and distinguishes the effects of Bcl6 in Tfr cells from the effects in Treg cells that control 461 
allergic inflammation.  462 
  463 




Bcl6-expressing Tfr cells are important for the humoral immune response through 465 
regulation of germinal center reactions (8-10).  Depending on the inflammatory milieu, Tfr cells 466 
can function as repressors or helpers of the GC reaction (18). Dysregulated functions of Tfr cells 467 
can lead to autoimmune diseases (61). Yet, the function of Bcl6 in regulatory T cells in the 468 
context of allergic airway inflammation is not fully understood. In this report, we have defined 469 
critical roles for Tfr cells in regulating the production of antigen specific IgE in an HDM extract 470 
induced airway inflammation model. This observation c firms a recent report that made similar 471 
observations on the function of Tfr in controlling IgE using a distinct genetic model (62).  472 
Our report defines an additional role for the balance of Bcl6 and Blimp-1 activity in Treg 473 
cells. Bcl6 represses and Blimp-1 activates ST2 expression in Treg cells in a cell-intrinsic 474 
manner. The adoptive transfer studies highlight the cell-intrinsic nature of this phenomenon since 475 
Bcl6 is only deleted in Foxp3-expressing cells in this model and would not impact the function 476 
of conventional T cells. The data suggest that Bcl6 is important in ST2- Treg cells to maintain the 477 
ST2- phenotype. In the absence of Bcl6, Blimp-1 expression is increased and there is an increase 478 
in the percentage of ST2+ Treg cells, and an increase in the amount of ST2 expressed per Treg 479 
cell. The ST2hi Treg cells would be more sensitive to an allergic environment and with increased 480 
expression of other effector molecules, Bcl6-deficint Tregs are potent at promoting allergic 481 
inflammation. The ability of Bcl6-deficient Tregs to recruit additional effectors of allergic 482 
inflammation further amplifies this activity. It isalso possible that increased ST2 expression 483 
decreases the stability of the Treg cells and an inflammatory environment converts them into 484 
ST2+ Tconv cells that could also potentially impact the generation of inflammation. 485 
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There has been significant characterization of the ST2-expressing Treg population in the 486 
colon and lung (40, 41, 43). ST2+ Treg cells are highly activated Th2-like Treg cells that retain 487 
Foxp3 expression and have increased GATA3 and producti n of Th2 cytokines in response to 488 
IL-33. IL-33 enhances the differentiation, accumulation and maintenance of ST2+ Treg in 489 
inflamed tissues (40-42). ST2+ Treg cells are effective in suppressing Th1 or Th17 cell 490 
inflammation in a colitis model and T cell proliferation, but fail to suppress, and potentially 491 
exacerbate, Th2 type responses in an allergic airway disease model (39, 40, 63). In support of a 492 
key role for Bcl6 in controlling this Treg population, Treg cells from germline Bcl6-deficient 493 
mice have increased ST2 expression, suppress Th1/Th17 cell-driven colitis, inhibit T cell 494 
proliferation, but promote Th2 type allergic airway inflammation (22). Human ST2+ Treg cells 495 
are found in the skin of systemic sclerosis patients (64). Similar to murine ST2+ Treg cells, these 496 
human ST2+ Treg cells and in vitro cultured human Treg cells produce Th2 cytokines in 497 
response to IL-33 (64, 65). Moreover, human Treg cells from HDM-sensitized asthmatic 498 
children have suppressive function on Th1 cells but fail o suppress allergen-specific Th2 499 
cytokine expression and amplify Th2 cytokines in response to IL-33 (66). However, the 500 
mechanisms controlling ST2+ Treg cell development are still not fully defined.  501 
In the RNA-seq analysis we identified a transcriptional signature associated with the 502 
ST2+ Treg cells in allergic lung inflammation. There is an enrichment of genes associated with 503 
type 2 immunity in the ST2+ Treg population, while genes associated with type 1 and type 17 504 
immunity are enhanced in the ST2- Treg cells. There is remarkable overlap between th 505 
transcriptional signature in the allergic ST2+ Treg cells and the VAT ST2+ Treg cells, adipose 506 
tissue resident Treg cells. While VAT ST2+ Treg cells maintain insulin sensitivity through 507 
control of inflammation in adipose tissue (67), ST2+ reg cells in lung promote allergic airway 508 
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inflammation (39). The function of VAT ST2+ Tregs might also be to promote modest type 2 509 
inflammation, and we have not examined whether this might be amplified in the Bcl6 fl/fl  Foxp3-510 
Cre mice. It also remains to be tested whether ST2+ Tregs might control cellular metabolism in 511 
the lung. The development and accumulation of VAT Treg cells depend on PPAR-γ which is 512 
regulated by the IL-33/ST2 pathway and mediated by IRF4 and BATF expression (46). The IL-513 
33/ST2 pathway subsequently activates GATA3 leading to expansion of ST2+ Treg cells and 514 
expression of Th2 cytokines (40, 41). However, naïve Il33-deficient mice develop ST2+ Treg 515 
cells (41), suggesting that there are unidentified signaling pathways for ST2+ Treg cell 516 
development. In this study, we defined Blimp1 as a key player for ST2+ Treg cell development. 517 
ST2 is preferentially expressed in Blimp1+ Treg cells (46), and we confirmed preferential 518 
expression of Blimp1 in ST2+ Treg cells. Blimp1-deficiency impairs ST2+ Treg cell development 519 
in vitro and in vivo. While there is a decreased number of ST2+ Treg cells in Prdm1 fl/fl  Foxp3-520 
Cre mice, these mice have comparable airway inflammtion to WT mice (data not shown). This 521 
observation could be due to several reasons including Blimp1 playing a critical role in the 522 
functions of Treg cells (68), and that Th2 cytokine production is already very low in wild type 523 
Tregs and cannot be lowered further by the absence of Blimp1. Blimp1 is a well-known 524 
repressor of Bcl6 transcription, and increased Bcl6 expression in Blimp1-deficient Treg cells 525 
likely contributes to the decreased development of ST2+ Treg cells from Blimp1-deficient Treg 526 
cells. Bcl6 negatively regulates a subset of genes associated with the ST2+ Treg subset including 527 
Prdm1 and Il1rl1, both of which contribute to the ST2+ Treg phenotype. Thus, Bcl6 and Blimp1 528 
are reciprocal regulators of Treg cell fate, similar to their reciprocal regulation of T helper cell 529 
and –B cell differentiation.  530 
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The functions of Bcl6 in regulating type 2 responses are complex. One of the first 531 
observations in Bcl6-/- mice was an increased Th2 responses (19, 20). However, this occurs 532 
through Bcl6 function in a number of cell types. One potential mechanism is through the 533 
repression of GATA3 which has been observed in conventional and regulatory T cells (22, 69). 534 
In our studies using mice that lacked Bcl6 specifically in Foxp3-expressing cells, we did not 535 
observe differences in GATA3 and ST2 expression in the ST2+ Treg population. Rather, we 536 
observed expansion of the ST2+ Treg population. Moreover, adoptively transferred Bcl6-537 
deficient ST2+ Treg cells induced airway inflammation in recipient mice after limited challenges, 538 
while ST2+ Bcl6-deficient Tconv or either subset of wild type ST2+ T cells did not. These data 539 
suggest that Bcl6 is important for the suppressive function of ST2+ Treg cells, and this study 540 
provides a first step to defining the mechanism. As deletion of ST2 normalized the increased Th2 541 
inflammation observed in the Bcl6fl/fl  Foxp3-Cre mice, it suggests that the IL-33/ST2 pathw y 542 
represents a major Bcl6 target that contributes to the control of allergic inflammation.  543 
The effects of ST2-deficiency can vary with the model examined. In our study, ST2 544 
deficiency did not alter overall inflammation or Th2 cells compared to control mice. In the 545 
Ova/Alum model, ST2-deficient mice developed attenuated airway inflammation that was linked 546 
to impaired DC activation (70). In the HDM model, ST2-deficient mice showed varying 547 
phenotypes depending on the dose of HDM, sensitization protocol, and analysis time point after 548 
last challenge. In a chronic HDM model, reduced airw y remodeling, AHR and airway 549 
inflammation were observed in ST2-deficient mice (71). However, in another HDM model, 550 
TSLP and IL-25 compensate for the loss of ST2 and diminished Th2 cells by expanding ILC2 551 
(72, 73). Thus, the effects of IL-33 signaling are sensitive to the context of the response. 552 
Regardless, the lack of a phenotype of ST2-deficiency i  our studies allowed us to examine the 553 
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effects in the context of cell-specific Bcl6-deficiency. ST2-deficiency in our studies resulted in 554 
decreased germinal center responses. This could be linked to the effects of ST2-deficiency on 555 
DC function (70, 74), rather than an intrinsic effect in Tfr cells.  556 
Our studies further define the complex roles of Tfr cells in regulating antibody responses, 557 
particularly IgE. Tfr cell-deficiency did not alter influenza-specific IgG production in an 558 
influenza infection model (59, 61). However, Tfr cells suppress antigen specific B cell function 559 
in several models (8-10). In our HDM induced airway inflammation model, Treg-specific Bcl6 560 
deficient mice (Bcl6fl/fl Foxp3-cre) similarly have reduced Tfr cell numbers but produced higher 561 
concentrations of HDM-specific IgE and total IgE than WT mice while producing comparable 562 
HDM specific IgG1. These data suggest that Tfr cells function as a repressor of IgE production. 563 
A recent report suggested that Tfr cells also limit allergic inflammation using an approach to 564 
delete Foxp3- and Cxcr5-expressing cells (62). Thisraises another important aspect of these two 565 
models in comparing the deletion of Tfr cells versus the loss of Tfr and other Treg functions by 566 
genetic deletion of Bcl6. Importantly, the effects of Bcl6 in the Tfr and Treg compartments are 567 
distinguished by the effects of ST2-deficiency, as Tfr cells are ST2-. Comparing these and other 568 
models will be required to refine the distinct function of Tfr and ST2+ Treg cells. 569 
In this report we have defined specific functions for Bcl6 in the Foxp3-expressing CD4+ 570 
T cell subset (Fig 7). In the context of HDM-induced allergic airway inflammation, Bcl6 is 571 
required for Tfr cells to develop and repress IgE production. In Treg cells, Bcl6 represses ST2, 572 
Gata3 and Blimp1, and in the absence of Bcl6 there is an expansion of the ST2+ Treg population, 573 
increased Th2 cell development, and increased allergic airway inflammation. Importantly, co-574 
deficiency of ST2 and Bcl6 distinguishes these two activities of Bcl6 in Foxp3-expressing cells 575 
by normalizing the airway inflammation without having an effect on the production of IgE. The 576 
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presence of the KLRG1+ Treg population in the ST2-deficient mice suggests that impact is 577 
specifically from IL-33 signaling, rather than a loss of the entire population. Each of these 578 
functions will be important to understand the detail d mechanisms of allergic airway 579 
inflammation. 580 
 581 
  582 
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Figure Legends 766 
 767 
Figure 1. Tfr-deficiency results in exacerbated airway inflammation 768 
WT, Bcl6 fl/fl Foxp3-cre and CD4-cre mice were challenged with 25 µg of HDM extract every 769 
other day for 16 days. (a) Schematic of HDM extract-induced airway inflammation model. (b-e) 770 
Flow cytometric analysis of CXCR5 and PD-1 on Tfr (gated CD4+ Foxp3+) and Tfh 771 
(CD4+Foxp3-) cells in mediastinal lymph nodes (mLNs). Representative dot plots (b, d) and 772 
average percentage (c, e) of Tfr and Tfh cells. (f, g) Flow cytometric analysis of GL7 and Fas on 773 
B220 B cells in mLN. Representative dot plot (f) and average percentage (g) of GC B cells. (h) 774 
Concentration of HDM specific IgE, IgG1 and total IgE in the serum measured by ELISA. (i-k) 775 
Numbers of total cells, eosinophils, neutrophils (i), IL-4-, IL-13- or IL-17-producing CD4+ T 776 
cells and eosinophils in the BAL (j) and lung (k). BAL and lung cells were re-stimulated with 777 
PMA/ionomycin for 5 hours to measure cytokine production using intracellular staining. Cells 778 
for flow cytometric analysis were gated on lymphocyte size and granularity, and the expression 779 
of CD4. Data are mean ± SEM of 8-10 mice per group and representative of three independent 780 
experiments. A Student’s unpaired two-tailed t test was used to generate p values. *p < 0.05, **p 781 
<0.01, ***p <0.001, ****p<0.0001 782 
 783 
Figure 2. Bcl6-deficiency in Treg cells leads to increased ST2+ Treg cell development 784 
Mice were challenged as in Fig. 1. (a, b) Flow cytometric analysis of ST2+ Treg in lung and 785 
mLN. (c) Number of ST2- Treg cells (comparison marked by ‘*’) and ST2+ Treg cells 786 
(comparison marked by ‘†’) in lung. (d) ST2 gMFI of ST2+ Treg cells in lung. (e, f) Flow 787 
cytometric analysis of ST2+ Tconv cells in lung and mLN. Staining for CXCR5 and ST2 is 788 
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shown on cells gated for lymphocyte size and granularity, CD4, and either Foxp3-positive (a-b) 789 
or Foxp3-negative (e-f) populations. Representative dot plots (a, e) and average percentages of 790 
ST2+ Treg in Treg (left) and in total CD4+ T cells (right) (b) or ST2+ Tconv in CD4+ Tconv (left) 791 
and in total CD4+ T cells (right) (f) are shown. Data are mean ± SEM of 8-10 mice per group and 792 
representative of three independent experiments. A Student’s unpaired two-tailed t test was used 793 
to generate p values. *p < 0.05, **p <0.01, ***p <0.001, ****p<0.0001; ††p <0.01, †††p <0.001.  794 
  795 
Figure 3. Pro-inflammatory transcriptional profile of ST2+ Treg cells in allergic airway 796 
inflammation  797 
Treg cells in mLN of HDM challenged WT mice were sorted based on the expression of CD4, 798 
Foxp3-YFP and activation markers. (a) TF gene expression was measured using qPCR. (b) Bcl6-799 
expressing Treg cell population was measured using intracellular staining. (c) Th2 cytokine gene 800 
expression was measured using qPCR. All gene expression was normalized to β2m expression. 801 
Student’s unpaired two-tailed t test was used to generate p values. *p < 0.05, **p <0.01, ***p 802 
<0.001, ****p<0.0001. (d-g) ST2+ Treg and ST2- Treg cells in lung of HDM challenged WT 803 
mice were sorted based on expression of CD4, Foxp3-YFP and ST2. (b-e) Analysis of RNA-seq 804 
of sorted ST2+ and ST2- Treg cells (each from two biological samples) from lung tissues of 805 
HDM challenged WT mice. (d) Volcano plot comparing gene expression in ST2+ vs ST2- Treg 806 
cells, (e) Heat maps showing differential expression of genes related to functions (left) and genes 807 
aligned with VAT Treg and peripheral Treg cells (pTreg) (right), (f) GSEA of ST2+ vs ST2- Treg 808 
cells with a VAT Treg vs pTreg cells gene list, (g)Ontology analysis of gene enrichment in 809 
biological process in ST2+ Treg cells 810 
 811 
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Figure 4. Bcl6 inhibits and Blimp1 promotes ST2 expression in Treg cells  812 
Splenic Treg cells from WT and Bcl6fl/fl Foxp3-cre mice were sorted and stimulated with anti-813 
CD3, anti-CD28 and IL-2 with or without IL-33 (10 ng/ml) for 3 days. Representative dot plots 814 
(a) and average percentage (b) of ST2+ reg cells. (c-d) qPCR analysis of Il1rl1 and transcription 815 
factor genes expression. (e) WT and Bcl6 fl/fl Foxp3-cre mice were challenged intranasally with 816 
0.5 µg of IL-33 for 3 consecutive days. Average percentage of ST2+ Treg cells in lung. (f-h) 817 
Splenic Treg cells from WT and Prdm1fl/fl Foxp3-cre mice were sorted and stimulated with anti-818 
CD3, anti-CD28 and IL-2 with or without IL-33 (10ng/ml) for 3 days. Representative dot plots (f) 819 
and average percentages (g) of ST2+ reg cells. (h) qPCR analysis of Il1rl1. (i) WT and 820 
Prdm1fl/fl Foxp3-cre mice were challenged to HDM as in Fig 1. Average percentage of ST2+ 821 
Treg cells in lung. (c, d, h) Gene expression was normalized to β2m expression. A Student’s 822 
unpaired two-tailed t test was used to generate p values. *p < 0.05, **p <0.01, ***p <0.001, 823 
**** p<0.0001. Data are mean ± SEM of 3-5 mice per group and representative of two 824 
independent experiments.  825 
 826 
Figure 5. ST2+ Treg cells promote airway inflammation.  827 
ST2+ Treg and Tconv cells were sorted from the lungs of HDM-challenged WT or Bcl6 fl/fl 828 
Foxp3-cre and adoptively transferred to recipient mice. Following transfer, mice were challenged 829 
three times with HDM. (a) Schematic adoptive transfer experiment. (b) Number of total BAL 830 
cells. Number of total lung cells, neutrophils, eosin phils (c) and total CD4+ T cells (d) in lung. 831 
(e) Percentage of donor CD4+ T cells, ST2+ Treg and ST2+ Tconv cells in lung of recipient mice. 832 
(f) ST2+ and ST2- Treg cells in lungs of HDM challenged WT or Bcl6 fl/fl Foxp3-cre mice were 833 
sorted based on the expression of CD4, Foxp3-YFP and ST2. Gene expression was measured 834 
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using qPCR and normalized to β2m expression. In (b) a student’s unpaired two-tailed t test was 835 
used to compare WT PBS to other groups. In (c-e) One-way ANOVA with a post hoc Tukey test 836 
was used to generate p values for multiple comparisons. ***p<0.001, ****p<0.0001. Data are 837 
mean ± SEM of 6 mice per group pooled from separate analyses. In (f) a Student’s unpaired two-838 
tailed t test was used to generate p values. *p < 0.05, **p <0.01, ***p <0.001, ****p<0.0001 839 
 840 
Figure 6. ST2-deficiency compensates for the lack of Bcl6 in Treg cells during allergic 841 
airway inflammation  842 
WT, Bcl6 fl/fl Foxp3-cre, Il1rl1-/- and Il1rl1-/-Bcl6fl/fl Foxp3-cre mice were challenged as in Fig 1. 843 
(a) Flow cytometric analysis of Tfr, Tfh and GC B cells in mLN. (b) Concentration of HDM 844 
specific IgE, IgG1 and total IgE in the serum measured by ELISA. Number of total BAL cells 845 
and eosinophils (c), lung cells (d), percentage of IL-13 producing CD4+ T cells (e) and GATA3 846 
expressing Tconv cells (f) in lung tissues. (g) GATA3 expressing Treg cells in lung. Lung cells 847 
were re-stimulated with PMA/ionomycin for 5 hours to measure cytokine production using 848 
intracellular staining. Cells for flow cytometric an lysis were gated on lymphocyte size and 849 
granularity, and the expression of CD4. Data are mean ± SEM of 8-10 mice per group and 850 
representative of three independent experiments. Studen ’s unpaired two-tailed t test was used to 851 
generate p values. *p < 0.05, **p <0.01, ***p <0.001, ****p<0.0001. 852 
 853 
Figure 7. Schematic diagram to describe the roles of Bcl6 on the regulation of IL-33 854 
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Antigen/Name Clone Fluorochrome Company Cat. No. 
B220 RA3-6B2 PerCP-Cy5.5 BioLegend 103236 
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IFN-γ XMG 1.2 PerCP-Cy5.5 eBioscience 45-7311-82 
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IL-13 eBio13A PE eBioscience 12-7133-82 
IL-17A eBio17B7 PE-Cy7 eBioscience 25-7177-82 
IL-4 11B11 AF647 BioLegend 504110 
KLRG1 2F1 
BV510 BD Biosciences 740156 
APC BD Biosciences 561620 
Ly6G 1A8 APC BioLegend 127613 
PD-1 29F.1A12 PerCP-Cy5.5 BioLegend 135208 
SiglecF E50-2440 PE BD Biosciences 552126 
ST2 U29-93 PE BD Biosciences 566309 
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Table E3. Sequence of ChIP primers  79 
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FIGURE LEGENDS 98 
Figure E1. Tfr-deficiency results in exacerbated airway inflammation 99 
Mice were sensitized and challenged to HDM as in Figure 1. (a) Representative dot plot (left) 100 
and average percentage (right) of Foxp3+ Treg cells in CD4+ T cells in mLN. Percentage of IL-4, 101 
IL-13 or IL-17 producing CD4+ T cells in BAL (b) and lung (c). (d) Number of IL-10 producing 102 
CD4+ T cells in BAL and lung. (e) Representative dot plts of IL-4 or IL-13 producing CD4+ T 103 
cells. Data are mean ± SEM of 8-10 mice per group and representative of three independent 104 
experiments.  A Student’s unpaired two-tailed t test was used to generate p values. **p <0.01, 105 
*** p <0.001, ****p<0.0001 106 
 107 
Figure E2. Bcl6-deficiency in Treg cells leads to increased ST2+ Treg cell development 108 
Mice were sensitized and challenged to HDM as in Figure 1 (a-c, e-h). (a) Average percentage of 109 
GATA3 positive cells in ST2+ or ST2- Treg cells in lung and mLN of WT mice. (b, c) Activation 110 
status, CD44high and CD62Llow, of Treg cells in mLN and lung. Representative dot pl s (b) and 111 
average percentage (c) of activated Treg cells. (d) Percentages ST2+ Treg and ST2+ Tconv cells 112 
in lung or mLN of naïve WT and Bcl6fl/fl Foxp3-Cre mice. Representative dot plots (e) and 113 
average percentage (f) of BCL6 expressing Treg cells in ST2+ or ST2- Treg cells in lung and 114 
mLN of WT mice. (g) ST2+ Treg and ST2+ Tconv cells in mesLN. (h) The percentage of Helios-115 
positive Treg cells in lung and mLN. (a-h) Data arem an ± SEM of 4-6 mice per group and 116 
representative of two independent experiments. A Student’s unpaired two-tailed t test was used 117 
to generate p values. **p <0.01, ***p <0.001, ****p<0.0001.  118 
 119 





Mice were sensitized and challenged to HDM as in Figure 1. Flow cytometric analysis of ST2+ 121 
Tregs and ST2+ Tconv cells in the lungs (a) and mLNs (b) of naïve and HDM challenged 122 
BALB/cJ and C57BL/6 mice. (c) Increase of cellularity between naïve and HDM challenged 123 
mice represented as fold change for each strain tested. A Student’s unpaired two-tailed t test was 124 
used to generate p values.  **p <0.01. 125 
 126 
Figure E4. Pro-inflammatory transcriptional profile of ST2+ Treg cells in allergic airway 127 
inflammation 128 
(a) Representative dot plot (left) and percentage (ri ht) of intracellular staining of Th2 cytokines 129 
in ST2+ or ST2- Treg cells. (b-d) ST2+ and ST2- Foxp3/YFP+ Treg cells were sorted from the 130 
lungs of HDM challenged WT mice. Gene expression was measured using qPCR and normalized 131 
to β2m expression. A Student’s unpaired two-tailed t test was used to generate p values. *p < 132 
0.05, **p <0.01, ***p <0.001, ****p<0.0001. 133 
 134 
Figure E5. Bcl6 inhibits and Blimp1 promotes ST2 expression in Treg cells  135 
(a, b) Naïve CD4+ T cells were isolated from spleen of WT and Bcl6fl/fl Foxp3-cre mice and 136 
stimulated with anti-CD3, anti-CD28, IL-2 and TGF-β with or without IL-33 (1 or10 ng/ml) for 137 
3 days. qPCR analysis of Il1rl1 (a) and Bcl6 expression (b). All gene expression was normalized 138 
to β2m expression. (c) WT mice were challenged with 0.5 µg IL-33 intranasally for 3 139 
consecutive days. ST2+ or ST2- Treg cells were sorted from lung based on CD4, Foxp3-YFP and 140 
ST2 expression. Transcription factor gene expression in ST2+ or ST2- Treg cells measured using 141 
qPCR and normalized to β2m expression. (d) Splenic Treg cells from Il1rl1-/- and Il1rl1-/-Bcl6fl/fl 142 





IL-33 (10 ng/ml) for 3 days. Il13, Il4 and Gata3 expression was measured using qPCR. (e, f) WT 144 
splenic Treg cells were sorted and stimulated with anti-CD3, anti-CD28, IL-2 with or without IL-145 
33 (10 ng/ml) for 3 days. On day 3, cells were harvested for ChIP analysis for H3K27ac at the 146 
Il1rl1 (e) and Prdm1 (f) gene loci. (g, h) Splenic Treg cells from WT C57BL/6 and BALB/cJ 147 
mice were sorted and stimulated with anti-CD3, anti-CD28 and IL-2 with or without IL-33 (10 148 
ng/ml) for 3 days. Representative dot plots (g) andverage percentage (h) of ST2+ Treg cells. (i-149 
k) WT and Prdm1fl/fl Foxp3-cre mice were sensitized and challenged to HDM as in Fig 1. (i) 150 
Average percentages of BCL6+ Treg cells in lung. Representative dot plots (j) and verage 151 
percentage (k) of Tfr cells in mLN. Data are mean ± SEM of 3-5 mice per group and 152 
representative of two independent experiments. A Student’s unpaired two-tailed t test was used 153 
to generate p values. *p < 0.05, **p <0.01, **** p<0.0001. 154 
 155 
Figure E6. ST2-deficiency compensates for the lack of Bcl6 in Treg cells during allergic 156 
airway inflammation 157 
(a) Flow cytometric analysis of ST2+ Treg and Tconv cells in lung and mLN. (b) Flow 158 
cytometric analysis of ST2 and KLRG1 expression and (c) total KLRG1 expressing Treg cells in 159 
lung. Data are mean ± SEM of 8-10 mice per group and representative of three independent 160 
experiments. A Student’s unpaired two-tailed t test was used to generate p values. *p < 0.05, **p 161 
<0.01, ***p <0.001, ****p<0.0001. 162 
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